DIR Return Create A Forum - Home
---------------------------------------------------------
MS Speaks
HTML https://msspeaks.createaforum.com
---------------------------------------------------------
*****************************************************
DIR Return to: OCREVUS (ocrelizumab)
*****************************************************
#Post#: 2466--------------------------------------------------
Fulminant hepatitis associated w/Echovirus 25 during Ocrevus
treatment...
DIR By: agate
Date: April 8, 2019, 7:03 pm
---------------------------------------------------------
I may be giving too much attention to rare, anecdotal instances
of adverse effects of the MS disease-modifying drugs, but here
is another one. This MS patient was taking Ocrevus but ended up
getting a liver transplant--and stopping the Ocrevus. This is
from JAMA Neurology (April 8, 2019), "Fulminant hepatitis
associated with Echovirus 25 during treatment with ocrelizumab
for multiple sclerosis":
HTML http://bit.ly/2WXuNQ6
This is from the discussion:
--- Quote ---
>
> Because ocrelizumab is a novel, high-efficacy
disease-modifying therapy for MS, it will probably be
extensively used. However, it may impair clearance of
enterovirus infections via B-cell depletion. Thus, in the case
of compatible symptoms, tests should be conducted for
enteroviruses. Given the bimodal clinical presentation (ie, the
patient had a severe rebound of liver enzyme levels after
initial improvement), patients receiving ocrelizumab with
enteroviral infection need close follow-up.
>
--- End Quote ---
#Post#: 2587--------------------------------------------------
Re: Fulminant hepatitis associated w/Echovirus 25 during Ocrevus
treatment...
DIR By: ewizabeth
Date: July 17, 2019, 10:54 am
---------------------------------------------------------
I was required to get tested for all forms of hepatitis prior to
starting Ocrevus so now I know why. I was completely negative on
all of them.
*****************************************************
Page 1 of 1